Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,982 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma

NCT01478048

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Compassionate Cancer Res Grp Corona, California, United States
  • Local Institution Corona, California, United States
  • Local Institution Long Beach, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 77 locations
View Trial Details
Completed

Phase I Trial of PX-478

NCT00522652

Conditions
Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • TGen Clinical Research Services at Scottsdale Healthcare Scottsdale, Arizona, United States
  • The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

NCT00884312

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • City of Hope National Medial Center Duarte, California, United States
  • University of California Medical Center San Francisco, California, United States
View all 23 locations
View Trial Details
Completed

A Study of Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity

NCT02567851

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
Locations
  • Queen Elizabeth Hospital Birmingham, United Kingdom
  • University Hospital of Wales Cardiff, United Kingdom
  • Beatson West of Scotland Cancer Center Glasgow, United Kingdom
  • St James University Hospital Leeds, United Kingdom
View Trial Details
Completed

Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia

NCT00278213

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Allgemeinen Krankenhaus Celle Kinderklinik Celle, Germany
  • St. Johannes Hospital - Medical Klinik II Duisburg, Germany
View all 19 locations
View Trial Details

Related conditions